INS and metabolic dysfunction-associated steatotic liver disease: In agreement with these animal data, an observational study showed that MK treatment in subjects with NAFLD significantly reduced of the homeostatic model assessment (HOMA) index serum glutamic‐pyruvic transaminase (SGPT) supporting the hypothesis of a beneficial effect of this molecule on both insulin sensitivity and inflammatory response [17].